Crispr Therapeutics, Vertex get world’s first regulatory green light for CRISPR-based medicine

Shares of Crispr Therapeutics, Vertex gain ground after first regulatory clearance for medicine based on transformative gene-editing technology
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.